In contrast, its ectopic upregulation suppresses tumor cell growth, migration, invasion, and EMT by targeting the 3′-UTR of SphK1 and SphK2 in the bladder and papillary thyroid cancers, respectively [172, 173]. The gene discussed is SPHK1; the disease is neoplasm.